LivingGLP1
Study S002534

Glycemic Velocity as a Modifiable Determinant of Early Retinal Microvascular and Choroidal Change During Initiation of GLP-1 Receptor Agonist Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Multimodal Retinal Imaging Cohort Study (the GLIDE Study)

Registration

Registration
NCT07723820
Acronym
GLIDE
Study type
OBSERVATIONAL
Status
NOT_YET_RECRUITING
Enrollment
126
Start
2026-09-01
Primary completion
2027-06-01
Lead sponsor
Thammasat University Hospital
Conditions
Type 2 Diabetes Mellitus; Diabetic Retinopathy (DR)
Interventions
DRUG:GLP-1 Receptor Agonists; DRUG:SGLT2 inhibitor
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in parafoveal deep-capillary-plexus (DCP) vessel density on OCT angiography [Baseline to Month 3]

Linked records (5)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0001072GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential.
Luo Y, BMC ophthalmology
2026Systematic reviewPMID 41501669DOIregistry reference BACKGROUND:41501669
R0006278Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Eleftheriadou A, Diabetologia
2024Nonrandomized studyPMID 38584180DOIregistry reference BACKGROUND:38584180
R0004204GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Kapoor I, Survey of ophthalmology
2023Systematic reviewPMID 37454782DOIregistry reference BACKGROUND:37454782
R0028636Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
Bain SC, Diabetes, obesity & metabolism
2019Narrative reviewPMID 30226298DOIregistry reference BACKGROUND:30226298
R0022278Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, The New England journal of medicine
2016Randomized trialPMID 27633186DOIregistry reference BACKGROUND:27633186